{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,23]],"date-time":"2026-06-23T17:18:31Z","timestamp":1782235111817,"version":"3.54.5"},"reference-count":46,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2013,9,11]],"date-time":"2013-09-11T00:00:00Z","timestamp":1378857600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Eur J Hum Genet"],"published-print":{"date-parts":[[2014,5]]},"DOI":"10.1038\/ejhg.2013.198","type":"journal-article","created":{"date-parts":[[2013,9,11]],"date-time":"2013-09-11T10:19:27Z","timestamp":1378894767000},"page":"667-674","source":"Crossref","is-referenced-by-count":29,"title":["Allele-specific Col1a1 silencing reduces mutant collagen in fibroblasts from Brtl mouse, a model for classical osteogenesis imperfecta"],"prefix":"10.1038","volume":"22","author":[{"given":"Julie","family":"Rousseau","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roberta","family":"Gioia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pierre","family":"Layrolle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Blandine","family":"Lieubeau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dominique","family":"Heymann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonio","family":"Rossi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joan C","family":"Marini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valerie","family":"Trichet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonella","family":"Forlino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2013,9,11]]},"reference":[{"key":"BFejhg2013198_CR1","doi-asserted-by":"publisher","first-page":"7195","DOI":"10.1073\/pnas.1231012100","volume":"100","author":"VM Miller","year":"2003","unstructured":"Miller VM, Xia H, Marrs GL et al: Allele-specific silencing of dominant disease genes. Proc Natl Acad Sci USA 2003; 100: 7195\u20137200.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFejhg2013198_CR2","doi-asserted-by":"publisher","first-page":"806","DOI":"10.1038\/35888","volume":"391","author":"A Fire","year":"1998","unstructured":"Fire A, Xu S, Montgomery MK, Kostas SA, Driver SE, Mello CC : Potent and specific genetic interference by double-stranded RNA in Caenorhabditis elegans. Nature 1998; 391: 806\u2013811.","journal-title":"Nature"},{"key":"BFejhg2013198_CR3","doi-asserted-by":"publisher","first-page":"950","DOI":"10.1126\/science.286.5441.950","volume":"286","author":"AJ Hamilton","year":"1999","unstructured":"Hamilton AJ, Baulcombe DC : A species of small antisense RNA in posttranscriptional gene silencing in plants. Science 1999; 286: 950\u2013952.","journal-title":"Science"},{"key":"BFejhg2013198_CR4","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1046\/j.1474-9728.2003.00054.x","volume":"2","author":"H Ding","year":"2003","unstructured":"Ding H, Schwarz DS, Keene A et al: Selective silencing by RNAi of a dominant allele that causes amyotrophic lateral sclerosis. Aging Cell 2003; 2: 209\u2013217.","journal-title":"Aging Cell"},{"key":"BFejhg2013198_CR5","doi-asserted-by":"publisher","first-page":"864","DOI":"10.1038\/sj.ejhg.5201230","volume":"12","author":"S Millington-Ward","year":"2004","unstructured":"Millington-Ward S, McMahon HP, Allen D et al: RNAi of COL1A1 in mesenchymal progenitor cells. Eur J Hum Genet 2004; 12: 864\u2013866.","journal-title":"Eur J Hum Genet"},{"key":"BFejhg2013198_CR6","doi-asserted-by":"publisher","first-page":"361","DOI":"10.7150\/ijms.5.361","volume":"5","author":"K Lindahl","year":"2008","unstructured":"Lindahl K, Rubin CJ, Kindmark A, Ljunggren O : Allele dependent silencing of COL1A2 using small interfering RNAs. Int J Med Sci 2008; 5: 361\u2013365.","journal-title":"Int J Med Sci"},{"key":"BFejhg2013198_CR7","doi-asserted-by":"publisher","first-page":"3846","DOI":"10.1096\/fj.08-110890","volume":"22","author":"RD Klootwijk","year":"2008","unstructured":"Klootwijk RD, Savelkoul PJ, Ciccone C et al: Allele-specific silencing of the dominant disease allele in sialuria by RNA interference. Faseb J 2008; 22: 3846\u20133852.","journal-title":"Faseb J"},{"key":"BFejhg2013198_CR8","doi-asserted-by":"publisher","first-page":"e49757","DOI":"10.1371\/journal.pone.0049757","volume":"7","author":"RE Loy","year":"2012","unstructured":"Loy RE, Lueck JD, Mostajo-Radji MA, Carrell EM, Dirksen RT : Allele-specific gene silencing in two mouse models of autosomal dominant skeletal myopathy. PLoS One 2012; 7: e49757.","journal-title":"PLoS One"},{"key":"BFejhg2013198_CR9","doi-asserted-by":"publisher","first-page":"550","DOI":"10.1126\/science.1068999","volume":"296","author":"TR Brummelkamp","year":"2002","unstructured":"Brummelkamp TR, Bernards R, Agami R : A system for stable expression of short interfering RNAs in mammalian cells. Science 2002; 296: 550\u2013553.","journal-title":"Science"},{"key":"BFejhg2013198_CR10","doi-asserted-by":"publisher","first-page":"948","DOI":"10.1101\/gad.981002","volume":"16","author":"PJ Paddison","year":"2002","unstructured":"Paddison PJ, Caudy AA, Bernstein E, Hannon GJ, Conklin DS : Short hairpin RNAs (shRNAs) induce sequence-specific silencing in mammalian cells. Genes Dev 2002; 16: 948\u2013958.","journal-title":"Genes Dev"},{"key":"BFejhg2013198_CR11","doi-asserted-by":"publisher","first-page":"540","DOI":"10.1038\/nrendo.2011.81","volume":"7","author":"A Forlino","year":"2011","unstructured":"Forlino A, Cabral WA, Barnes AM, Marini JC : New perspectives on osteogenesis imperfecta. Nat Rev Endocrinol 2011; 7: 540\u2013557.","journal-title":"Nat Rev Endocrinol"},{"key":"BFejhg2013198_CR12","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1002\/humu.20429","volume":"28","author":"JC Marini","year":"2007","unstructured":"Marini JC, Forlino A, Cabral WA et al: Consortium for osteogenesis imperfecta mutations in the helical domain of type I collagen: regions rich in lethal mutations align with collagen binding sites for integrins and proteoglycans. Hum Mutat 2007; 28: 209\u2013221.","journal-title":"Hum Mutat"},{"key":"BFejhg2013198_CR13","first-page":"367","volume":"6","author":"E Monti","year":"2010","unstructured":"Monti E, Mottes M, Fraschini P et al: Current and emerging treatments for the management of osteogenesis imperfecta. Ther Clin Risk Manag 2010; 6: 367\u2013381.","journal-title":"Ther Clin Risk Manag"},{"key":"BFejhg2013198_CR14","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1007\/s11154-008-9074-4","volume":"9","author":"MS Cheung","year":"2008","unstructured":"Cheung MS, Glorieux FH : Osteogenesis imperfecta: update on presentation and management. Rev Endocr Metab Disord 2008; 9: 153\u2013160.","journal-title":"Rev Endocr Metab Disord"},{"key":"BFejhg2013198_CR15","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1002\/jbmr.1717","volume":"28","author":"BP Sinder","year":"2013","unstructured":"Sinder BP, Eddy MM, Ominsky MS, Caird MS, Marini JC, Kozloff KM : Sclerostin antibody improves skeletal parameters in a Brtl\/+ mouse model of osteogenesis imperfecta. J Bone Miner Res 2013; 28: 73\u201380.","journal-title":"J Bone Miner Res"},{"key":"BFejhg2013198_CR16","first-page":"183","volume":"12","author":"O Semler","year":"2012","unstructured":"Semler O, Netzer C, Hoyer-Kuhn H, Becker J, Eysel P, Schoenau E : First use of the RANKL antibody denosumab in osteogenesis imperfecta type VI. J Musculoskelet Neuronal Interact 2012; 12: 183\u2013188.","journal-title":"J Musculoskelet Neuronal Interact"},{"key":"BFejhg2013198_CR17","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1136\/jmg.16.2.101","volume":"16","author":"DO Sillence","year":"1979","unstructured":"Sillence DO, Senn A, Danks DM : Genetic heterogeneity in osteogenesis imperfecta. J Med Genet 1979; 16: 101\u2013116.","journal-title":"J Med Genet"},{"key":"BFejhg2013198_CR18","doi-asserted-by":"publisher","first-page":"3183","DOI":"10.1634\/stemcells.2007-0466","volume":"25","author":"F Li","year":"2007","unstructured":"Li F, Wang X, Niyibizi C : Distribution of single-cell expanded marrow derived progenitors in a developing mouse model of osteogenesis imperfecta following systemic transplantation. Stem Cells 2007; 25: 3183\u20133193.","journal-title":"Stem Cells"},{"key":"BFejhg2013198_CR19","doi-asserted-by":"publisher","first-page":"1717","DOI":"10.1182\/blood-2007-08-105809","volume":"111","author":"PV Guillot","year":"2008","unstructured":"Guillot PV, Abass O, Bassett JH et al: Intrauterine transplantation of human fetal mesenchymal stem cells from first-trimester blood repairs bone and reduces fractures in osteogenesis imperfecta mice. Blood 2008; 111: 1717\u20131725.","journal-title":"Blood"},{"key":"BFejhg2013198_CR20","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1182\/blood-2008-12-195859","volume":"114","author":"C Panaroni","year":"2009","unstructured":"Panaroni C, Gioia R, Lupi A et al: In utero transplantation of adult bone marrow decreases perinatal lethality and rescues the bone phenotype in the knockin murine model for classical, dominant osteogenesis imperfecta. Blood 2009; 114: 459\u2013468.","journal-title":"Blood"},{"key":"BFejhg2013198_CR21","doi-asserted-by":"publisher","first-page":"1227","DOI":"10.1182\/blood.V97.5.1227","volume":"97","author":"EM Horwitz","year":"2001","unstructured":"Horwitz EM, Prockop DJ, Gordon PL et al: Clinical responses to bone marrow transplantation in children with severe osteogenesis imperfecta. Blood 2001; 97: 1227\u20131231.","journal-title":"Blood"},{"key":"BFejhg2013198_CR22","doi-asserted-by":"publisher","first-page":"1607","DOI":"10.1097\/01.TP.0000159029.48678.93","volume":"79","author":"K Le Blanc","year":"2005","unstructured":"Le Blanc K, Gotherstrom C, Ringden O et al: Fetal mesenchymal stem-cell engraftment in bone after in utero transplantation in a patient with severe osteogenesis imperfecta. Transplantation 2005; 79: 1607\u20131614.","journal-title":"Transplantation"},{"key":"BFejhg2013198_CR23","doi-asserted-by":"publisher","first-page":"576","DOI":"10.3109\/14653249.2010.507330","volume":"12","author":"DJ Prockop","year":"2010","unstructured":"Prockop DJ, Brenner M, Fibbe WE et al: Defining the risks of mesenchymal stromal cell therapy. Cytotherapy 2010; 12: 576\u2013578.","journal-title":"Cytotherapy"},{"key":"BFejhg2013198_CR24","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1038\/nbt831","volume":"21","author":"AL Jackson","year":"2003","unstructured":"Jackson AL, Bartz SR, Schelter J et al: Expression profiling reveals off-target gene regulation by RNAi. Nat Biotechnol 2003; 21: 635\u2013637.","journal-title":"Nat Biotechnol"},{"key":"BFejhg2013198_CR25","doi-asserted-by":"publisher","first-page":"37923","DOI":"10.1074\/jbc.274.53.37923","volume":"274","author":"A Forlino","year":"1999","unstructured":"Forlino A, Porter FD, Lee EJ, Westphal H, Marini JC : Use of the Cre\/lox recombination system to develop a non-lethal knock-in murine model for osteogenesis imperfecta with an alpha1(I) G349C substitution. Variability in phenotype in BrtlIV mice. J Biol Chem 1999; 274: 37923\u201337931.","journal-title":"J Biol Chem"},{"key":"BFejhg2013198_CR26","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1016\/j.ab.2004.07.018","volume":"334","author":"JT Chang","year":"2004","unstructured":"Chang JT : An economic and efficient method of RNAi vector constructions. Anal Biochem 2004; 334: 199\u2013200.","journal-title":"Anal Biochem"},{"key":"BFejhg2013198_CR27","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1038\/cgt.2009.89","volume":"17","author":"J Rousseau","year":"2010","unstructured":"Rousseau J, Escriou V, Perrot P et al: Advantages of bioluminescence imaging to follow siRNA or chemotherapeutic treatments in osteosarcoma preclinical models. Cancer Gene Ther 2010; 17: 387\u2013397.","journal-title":"Cancer Gene Ther"},{"key":"BFejhg2013198_CR28","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1073\/pnas.232688199","volume":"100","author":"XF Qin","year":"2003","unstructured":"Qin XF, An DS, Chen IS, Baltimore D : Inhibiting HIV-1 infection in human T cells by lentiviral-mediated delivery of small interfering RNA against CCR5. Proc Natl Acad Sci USA 2003; 100: 183\u2013188.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFejhg2013198_CR29","doi-asserted-by":"publisher","first-page":"6653","DOI":"10.1038\/sj.onc.1210492","volume":"26","author":"C Chipoy","year":"2007","unstructured":"Chipoy C, Brounais B, Trichet V et al: Sensitization of osteosarcoma cells to apoptosis by oncostatin M depends on STAT5 and p53. Oncogene 2007; 26: 6653\u20136664.","journal-title":"Oncogene"},{"key":"BFejhg2013198_CR30","doi-asserted-by":"publisher","first-page":"1877","DOI":"10.1002\/pmic.200600919","volume":"7","author":"A Forlino","year":"2007","unstructured":"Forlino A, Tani C, Rossi A et al: Differential expression of both extracellular and intracellular proteins is involved in the lethal or nonlethal phenotypic variation of BrtlIV, a murine model for osteogenesis imperfecta. Proteomics 2007; 7: 1877\u20131891.","journal-title":"Proteomics"},{"key":"BFejhg2013198_CR31","doi-asserted-by":"publisher","first-page":"604","DOI":"10.1016\/j.matbio.2007.06.005","volume":"26","author":"A Forlino","year":"2007","unstructured":"Forlino A, Kuznetsova NV, Marini JC, Leikin S : Selective retention and degradation of molecules with a single mutant alpha1(I) chain in the Brtl IV mouse model of OI. Matrix Biol 2007; 26: 604\u2013614.","journal-title":"Matrix Biol"},{"key":"BFejhg2013198_CR32","doi-asserted-by":"publisher","first-page":"1465","DOI":"10.1002\/stem.1107","volume":"30","author":"R Gioia","year":"2012","unstructured":"Gioia R, Panaroni C, Besio R et al: Impaired osteoblastogenesis in a murine model of dominant osteogenesis imperfecta: a new target for osteogenesis imperfecta pharmacological therapy. Stem Cells 2012; 30: 1465\u20131476.","journal-title":"Stem Cells"},{"key":"BFejhg2013198_CR33","doi-asserted-by":"publisher","first-page":"3451","DOI":"10.1093\/nar\/25.17.3451","volume":"25","author":"G Grassi","year":"1997","unstructured":"Grassi G, Forlino A, Marini JC : Cleavage of collagen RNA transcripts by hammerhead ribozymes in vitro is mutation-specific and shows competitive binding effects. Nucleic Acids Res 1997; 25: 3451\u20133458.","journal-title":"Nucleic Acids Res"},{"key":"BFejhg2013198_CR34","doi-asserted-by":"publisher","first-page":"752","DOI":"10.1086\/383252","volume":"74","author":"WA Cabral","year":"2004","unstructured":"Cabral WA, Marini JC : High proportion of mutant osteoblasts is compatible with normal skeletal function in mosaic carriers of osteogenesis imperfecta. Am J Hum Genet 2004; 74: 752\u2013760.","journal-title":"Am J Hum Genet"},{"key":"BFejhg2013198_CR35","doi-asserted-by":"publisher","first-page":"448","DOI":"10.1172\/JCI118434","volume":"97","author":"Q Wang","year":"1996","unstructured":"Wang Q, Marini JC : Antisense oligodeoxynucleotides selectively suppress expression of the mutant alpha 2(I) collagen allele in type IV osteogenesis imperfecta fibroblasts. A molecular approach to therapeutics of dominant negative disorders. J Clin Invest 1996; 97: 448\u2013454.","journal-title":"J Clin Invest"},{"key":"BFejhg2013198_CR36","doi-asserted-by":"publisher","first-page":"4013","DOI":"10.1093\/nar\/28.20.4013","volume":"28","author":"PA Dawson","year":"2000","unstructured":"Dawson PA, Marini JC : Hammerhead ribozymes selectively suppress mutant type I collagen mRNA in osteogenesis imperfecta fibroblasts. Nucleic Acids Res 2000; 28: 4013\u20134020.","journal-title":"Nucleic Acids Res"},{"key":"BFejhg2013198_CR37","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1038\/mt.2011.263","volume":"20","author":"GR Rettig","year":"2012","unstructured":"Rettig GR, Behlke MA : Progress toward in vivo use of siRNAs-II. Mol Ther 2012; 20: 483\u2013512.","journal-title":"Mol Ther"},{"key":"BFejhg2013198_CR38","doi-asserted-by":"publisher","first-page":"e140","DOI":"10.1371\/journal.pgen.0020140","volume":"2","author":"DS Schwarz","year":"2006","unstructured":"Schwarz DS, Ding H, Kennington L et al: Designing siRNA that distinguish between genes that differ by a single nucleotide. PLoS Genet 2006; 2: e140.","journal-title":"PLoS Genet"},{"key":"BFejhg2013198_CR39","doi-asserted-by":"publisher","first-page":"e2248","DOI":"10.1371\/journal.pone.0002248","volume":"3","author":"Y Ohnishi","year":"2008","unstructured":"Ohnishi Y, Tamura Y, Yoshida M, Tokunaga K, Hohjoh H : Enhancement of allele discrimination by introduction of nucleotide mismatches into siRNA in allele-specific gene silencing by RNAi. PLoS One 2008; 3: e2248.","journal-title":"PLoS One"},{"key":"BFejhg2013198_CR40","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1016\/S0092-8674(03)00759-1","volume":"115","author":"DS Schwarz","year":"2003","unstructured":"Schwarz DS, Hutvagner G, Du T, Xu Z, Aronin N, Zamore PD : Asymmetry in the assembly of the RNAi enzyme complex. Cell 2003; 115: 199\u2013208.","journal-title":"Cell"},{"key":"BFejhg2013198_CR41","doi-asserted-by":"publisher","first-page":"711","DOI":"10.1038\/nchembio839","volume":"2","author":"D Bumcrot","year":"2006","unstructured":"Bumcrot D, Manoharan M, Koteliansky V, Sah DW : RNAi therapeutics: a potential new class of pharmaceutical drugs. Nat Chem Biol 2006; 2: 711\u2013719.","journal-title":"Nat Chem Biol"},{"key":"BFejhg2013198_CR42","doi-asserted-by":"publisher","first-page":"2145","DOI":"10.1242\/jcs.068833","volume":"123","author":"KY Tsang","year":"2010","unstructured":"Tsang KY, Chan D, Bateman JF, Cheah KS : In vivo cellular adaptation to ER stress: survival strategies with double-edged consequences. J Cell Sci 2010; 123: 2145\u20132154.","journal-title":"J Cell Sci"},{"key":"BFejhg2013198_CR43","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1002\/(SICI)1096-9896(199802)184:2<212::AID-PATH996>3.0.CO;2-Z","volume":"184","author":"T Kojima","year":"1998","unstructured":"Kojima T, Miyaishi O, Saga S, Ishiguro N, Tsutsui Y, Iwata H : The retention of abnormal type I procollagen and correlated expression of HSP 47 in fibroblasts from a patient with lethal osteogenesis imperfecta. J Pathol 1998; 184: 212\u2013218.","journal-title":"J Pathol"},{"key":"BFejhg2013198_CR44","doi-asserted-by":"publisher","first-page":"818","DOI":"10.1126\/science.1171242","volume":"326","author":"N Cartier","year":"2009","unstructured":"Cartier N, Hacein-Bey-Abina S, Bartholomae CC et al: Hematopoietic stem cell gene therapy with a lentiviral vector in X-linked adrenoleukodystrophy. Science 2009; 326: 818\u2013823.","journal-title":"Science"},{"key":"BFejhg2013198_CR45","doi-asserted-by":"publisher","first-page":"5332","DOI":"10.1182\/blood-2010-09-306761","volume":"117","author":"A Biffi","year":"2011","unstructured":"Biffi A, Bartolomae CC, Cesana D et al: Lentiviral vector common integration sites in preclinical models and a clinical trial reflect a benign integration bias and not oncogenic selection. Blood 2011; 117: 5332\u20135339.","journal-title":"Blood"},{"key":"BFejhg2013198_CR46","doi-asserted-by":"publisher","first-page":"3741","DOI":"10.1093\/nar\/gkr1214","volume":"40","author":"P Perez-Pinera","year":"2012","unstructured":"Perez-Pinera P, Ousterout DG, Brown MT, Gersbach CA : Gene targeting to the ROSA26 locus directed by engineered zinc finger nucleases. Nucleic Acids Res 2012; 40: 3741\u20133752.","journal-title":"Nucleic Acids Res"}],"container-title":["European Journal of Human Genetics"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/ejhg2013198.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/ejhg2013198","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/ejhg2013198.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,18]],"date-time":"2023-05-18T17:09:18Z","timestamp":1684429758000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/ejhg2013198"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,9,11]]},"references-count":46,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2014,5]]}},"alternative-id":["BFejhg2013198"],"URL":"https:\/\/doi.org\/10.1038\/ejhg.2013.198","relation":{},"ISSN":["1018-4813","1476-5438"],"issn-type":[{"value":"1018-4813","type":"print"},{"value":"1476-5438","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,9,11]]}}}